The objective of our study was to examine the expression of tumor-progression-associated MMPs (MMP-1, MMP-2, and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in locally invasive PTC and their relation to clinicopathological features. Here, MMP1 is linked to neoplasm.